Rights and permissions
About this article
Cite this article
SMC accepts imatinib for GIST. Pharmacoecon. Outcomes News 652, 10 (2012). https://doi.org/10.2165/00151234-201206520-00031
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201206520-00031